By staff writers

May 2, 2013 -- Medical isotope firm Shine Medical Technologies announced it has reached a milestone in its development program with Phoenix Nuclear Labs by successfully producing 3 x 1011 neutrons per second with a deuterium-deuterium fusion reaction.

Meeting the milestone is a major step in validating Shine's technology for producing molybdenum-99 (Mo-99), according to the firm.

Most Mo-99 used in the U.S. has been produced in foreign nuclear reactors using a highly enriched uranium process, which is a nuclear proliferation threat. In collaboration with Shine, the Morgridge Institute for Research is working with the U.S. Department of Energy's National Nuclear Security Administration to develop a U.S. supply of Mo-99 produced without the use of highly enriched uranium to ensure that patients have continued access to diagnostic nuclear medicine procedures, Shine said.

Shine plans to build a production facility in Janesville, WI, that will produce more than half of the U.S. demand for Mo-99 by 2016. This new facility will use eight neutron generators manufactured by Phoenix Nuclear Labs, according to Shine.

Copyright © 2013

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking